样式: 排序: IF: - GO 导出 标记为已读
-
Single-cell RNA sequencing of chronic idiopathic erythroderma defines disease-specific markers. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-12-16 Sumanth Chennareddy,Katharina Rindler,Shannon Meledathu,Malini P Naidu,Natalia Alkon,John R Ruggiero,Lisa Szmolyan,Wolfgang Weninger,Wolfgang M Bauer,Johannes Griss,Constanze Jonak,Patrick M Brunner
BACKGROUND Chronic erythroderma is a potentially life-threatening condition that can be caused by a variety of diseases, but approximately 30% of cases remain idiopathic, often with insufficient treatment options. OBJECTIVE To establish a molecular disease map of chronic idiopathic erythroderma. METHODS We performed single-cell RNA sequencing combined with T-cell receptor sequencing of blood and skin
-
Successful hematopoietic cell transplantation utilizing myeloablative reduced-toxicity conditioning in Chediak-Higashi syndrome. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-12-16 Alan Bidgoli,Binni Kunvarjee,Andromachi Scaradavou,Richard J O'Reilly,Jaap Jan Boelens,Susan E Prockop,Joseph H Oved
-
Clinical Response and Corresponding Blood Transcriptome Pathways Pre- And Post-Treatment Of Hereditary Angioedema Prodromes Compared To Active Swelling Attacks. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-12-13 Debajyoti Ghosh,John Anderson,Umesh Singh,Cheryl K Bernstein,Jonathan A Bernstein
RATIONALE Approximately 85% Hereditary angioedema (HAE) attacks are associated with prodromal symptoms. We investigated the clinical effect of treating HAE-C1 inhibitor (HAE-C1INH) Type 1 patients with Conestat Alfa® (recombinant human C1-INH) during their prodrome versus an active swelling episode and associated changes in blood transcriptomic genes and pathways pre- vs. post-treatment. METHODS A
-
Mortality in adult patients with chronic spontaneous urticaria: A real world cohort study. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-12-13 Pavel Kolkhir,Katja Bieber,Tomasz Hawro,Khalaf Kridin,Marlene A Ludwig,Henning Olbrich,Martin Metz,Artem Vorobyev,Ralf J Ludwig,Marcus Maurer
BACKGROUND Chronic spontaneous urticaria (CSU), a common and debilitating disease, is widely held not to be life-limiting, but the mortality of CSU has not been investigated. OBJECTIVE To assess all-cause mortality in CSU patients, risk for comorbidities that are leading causes of death and impact of guideline-recommended urticaria treatments on mortality rates. METHODS This is a retrospective population-based
-
CAR-T cell therapy : recent updates and challenges in autoimmune diseases. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-12-13 Blandine Caël,Elodie Bôle-Richard,Francine Garnache-Ottou,François Aubin
Chimeric antigen receptor T cell (CAR-T) therapy has revolutionized the treatment of hematological malignancies, demonstrating significant clinical efficacy and leading to FDA approval of several CAR-T cell-based products. This success has prompted exploration of CAR-T cell therapy in other disease areas, including autoimmune diseases (AIDs). CAR-T cells targeting B cells have been shown to provide
-
Splice site and de novo variants can cause PLCG2-associated immune dysregulation with cold urticaria (PLAID-CU). J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-12-10 Sophia R Chou,Alexis C Bailey,Kathleen Baysac,Andrew J Oler,Joshua D Milner,Michael J Ombrello
BACKGROUND Phospholipase Cγ2 (PLCγ2) is an important signaling molecule that receives and transmits signals from various cell surface receptors in most hematopoietic lineages. Variants of PLCG2 cause PLCγ2-associated immune dysregulation (PLAID), a family of conditions that are classified by mutational effect. PLAID with cold urticaria (PLAID-CU) is caused by in-frame deletions of PLCG2 that are dominant
-
Neonatal gut microbiota and risk of developing food sensitization and allergy. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-12-09 Ryohei Shibata,Yumiko Nakanishi,Wataru Suda,Taiji Nakano,Noriko Sato,Yosuke Inaba,Yohei Kawasaki,Masahira Hattori,Naoki Shimojo,Hiroshi Ohno
BACKGROUND Food sensitization (FS) develops in early infancy and is a risk factor for subsequent food allergy (FA). Recent evidence suggests relationships of gut microbiota with FS and FA. However, little is known about the role of neonatal gut microbiota in the pathobiology of these manifestations. OBJECTIVES We sought to characterize gut microbiota in children using an enterotyping approach and determine
-
Clinician views of patient navigators for underserved adults with asthma: A qualitative analysis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-12-09 Andrea J Apter,Tyra Bryant-Stephens,Hami Park,Lenisha Fergus,Kadel LaRose,Philycia Foote,Freya Nezir,Anna U Morgan,Xiaoyan Han,Knashawn H Morales,Heather Klusaritz
-
Commentary: Parapsoriasis en plaque, deciphered at single-cell resolution. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-12-05 Sijia Wang,Raymond J Cho
-
A genome-wide meta-analysis reveals shared and population-specific variants for allergic sensitization. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-12-03 Emiko Noguchi,Wataru Morii,Haruna Kitazawa,Tomomitsu Hirota,Kyuto Sonehara,Hironori Masuko,Yukinori Okada,Nobuyuki Hizawa
BACKGROUND Allergic diseases are major causes of morbidity in both developed and developing countries and represent a global burden on health care systems. Allergic sensitization is defined as the production of immunoglobulin E (IgE) specific to common environmental allergens, and it is an important indicator in the assessment of allergic diseases. OBJECTIVES This study aimed to clarify the genetic
-
Ruxolitinib Treatment Ameliorates Clinical, Immunological, and Transcriptomic Aberrations in Patients with STAT3 Gain-of-Function Disease. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-12-02 Feyza Bayram Catak,Mehmet Cihangir Catak,Royala Babayeva,John Toubia,Nicholas I Warnock,Fatih Celmeli,Demet Hafizoglu,Nalan Yakici,Basak Kayaoglu,Naz Surucu,Ezgi Yalcin Gungoren,Salim Can,Melek Yorgun Altunbas,Ibrahim Serhat Karakus,Ayca Kiykim,Fazil Orhan,Sevgi Bilgic Eltan,Elif Karakoc-Aydiner,Ahmet Ozen,Baran Erman,Mayda Gursel,Chung Hoow Kok,Gökhan Cildir,Safa Baris
BACKGROUND STAT3 gain-of-function (GOF) disease presents with lymphoproliferation, autoimmunity, and failure to thrive. While JAK inhibitors have alleviated symptoms, their effects on disease pathogenesis remain unclear. OBJECTIVE We prospectively investigated the clinical, immunological, and transcriptomic responses of four STAT3 GOF patients under long-term ruxolitinib treatment. METHODS We conducted
-
Inborn errors of immunity reveal the molecular requirements for the generation and maintenance of human IL-9 expressing cells. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-30 Geetha Rao,Corinne D Mack,Tina Nguyen,Natalie Wong,Kathryn Payne,Lisa Worley,Paul E Gray,Melanie Wong,Peter Hsu,Michael O Stormon,Kahn Preece,Daniel Suan,Michael O'Sullivan,Annaliesse K Blincoe,Jan Sinclair,Satoshi Okada,Sophie Hambleton,Peter D Arkwright,Kaan Boztug,Polina Stepensky,Megan A Cooper,Liliana Bezrodnik,Kari C Nadeau,Hassan Abolhassani,Roshini S Abraham,Mikko R J Seppänen,Vivien Béziat
BACKGROUND CD4+ T cells play essential roles in adaptive immunity. Distinct CD4+ T cell subsets - Th1, Th2, Th17, Th22, T follicular helper and regulatory T cells - have been identified and their contributions to host defence and immune regulation are increasingly well-defined. IL-9 producing Th9 cells were first described in 2008 and appear to play both protective and pathogenic roles in human immunity
-
Features of hyperinflammation link the biology of EBV infection and cytokine storm syndromes. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-30 Meng Liu,Kailey E Brodeur,Jacob R Bledsoe,Claudia N Harris,Jill Joerger,Rachel Weng,Evan E Hsu,Michael T Lam,Casey A Rimland,Courtney E LeSon,Jian Yue,Lauren A Henderson,Fatma Dedeoglu,Jane W Newburger,Peter A Nigrovic,Mary Beth F Son,Pui Y Lee
BACKGROUND Overt immune activation by viral infections can lead to cytokine storm syndromes, such as hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS). OBJECTIVE We aim to compare the immune response to different viral pathogens to understand the connection between infections and cytokine storm syndromes. METHODS We recruited children who presented to the emergency room
-
Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for the diagnosis of inborn errors of immunity (IEI). J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-30 Giuliana Giardino,Gigliola Di Matteo,Silvia Giliani,Simona Ferrari,Vassilios Lougaris,Raffaele Badolato,Francesca Conti,Roberta Romano,Maria Pia Cicalese,Silvia Ricci,Federica Barzaghi,Antonio Marzollo,Cristina Cifaldi,Davide Montin,Lorenzo Lodi,Emilia Cirillo,Baldassarre Martire,Antonio Trizzino,Mayla Sgrulletti,Viviana Moschese,Marika Comegna,Giuseppe Castaldo,Alberto Tommasini,Chiara Azzari,Caterina
BACKGROUND Inborn errors of immunity (IEIs) are more than 500 different rare congenital disorders of the immune system characterized by susceptibility to infections and immune dysregulation. The significant overlap of the clinical features among the different forms may lead to diagnostic delay. High throughput sequencing techniques may allow a timely genetic definition. Guidelines for the use and the
-
Eosinophilic Esophagitis Drives Tissue Fibroblast Regenerative Programs Towards Pathologic Dysfunction. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-29 Medet Jumabay,Edsel M Abud,Kevin Okamoto,Paramita Dutta,Austin W T Chiang,Haining Li,Mario Manresa,Yanfang P Zhu,Dana Frederick,Richard Kurten,Ben Croker,Nathan E Lewis,Joshua L Kennedy,Ranjan Dohil,Michael Croft,Ferhat Ay,Joshua B Wechsler,Seema S Aceves
BACKGROUND Pathologic tissue remodeling with scarring and tissue rigidity has been demonstrated in inflammatory, autoimmune, and allergic diseases. Eosinophilic esophagitis (EoE) is an allergic disease that is diagnosed and managed by repeated biopsy procurement, allowing an understanding of tissue fibroblast dysfunction. While EoE associated tissue remodeling causes clinical dysphagia, food impactions
-
Indoor bioaerosols and asthma: Overview, implications, and mitigation strategies. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-27 Karen C Dannemiller,Laura A Conrad,Sarah R Haines,Yvonne J Huang,Linsey C Marr,Jeffrey A Siegel,Sumaiya Hassan,Jon C King,Aaron J Prussin,Austin Shamblin,Matthew S Perzanowski
Aerosolized particles with a biological origin are called bioaerosols. Bioaerosols from plants, animals, fungi, bacteria and viruses are an important class of environmental exposures that are clinically relevant to asthma. However, there are important differences in the pathways by which various bioaerosols impact asthma. Additionally, differences in individual susceptibility to different bioaerosols
-
Cytokine testing and challenges for diagnostic and clinical monitoring use. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-27 Vijaya Knight,Lusia Sepiashvili
-
Therapeutic B Cell Depletion: Mechanisms, Clinical Applications, and Implications for Secondary Immunodeficiency. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-27 Ahmed Elmoursi,Sara Barmettler
-
Effects of dupilumab on mannitol airway hyperresponsiveness in uncontrolled severe asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-26 Kirsten E Stewart,Chris RuiWen Kuo,Rory Chan,Brian J Lipworth
BACKGROUND Airway hyper-responsiveness (AHR) is a hallmark of persistent asthma. However, effects of IL-4/13 blockade with dupilumab (Dupi) on AHR are unknown. OBJECTIVE To investigate the effect of 12 weeks of Dupi on AHR, asthma control and quality of life. METHODS After a 4-week run-in on beclomethasone/formoterol(BDP/FM) MART (baseline), participants with uncontrolled type-2 high severe asthma
-
Flow cytometry-based basophil and mast cell activation tests in allergology: State of the art. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-23 Didier G Ebo,Rajia Bahri,Alexander Eggel,Vito Sabato,Chiara Tontini,Jessy Elst
The major challenge in allergy diagnosis is development of accessible and reliable diagnostics that can predict the clinical outcome following exposure to culprit allergen(s) or cross-reactive molecules and identification of safer alternatives than the current state-of-the-art methods. There is accumulating evidence that flow-based analyses for the quantification of activated basophils and mast cells
-
Aspergillus-mediated allergic airway inflammation is triggered by dendritic cell recognition of a defined spore morphotype. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-22 E L Houlder,S Gago,G Vere,J Furlong-Silva,D P Conn,E Hickey,S Khan,D Thomson,M W Shepherd,R Lebedinec,G D Brown,W Horsnell,M Bromley,A S MacDonald,P C Cook
BACKGROUND Exposure to fungi, especially Aspergillus fumigatus (A.f.), can elicit potent allergic inflammation that triggers and worsens asthmatic disease. Dendritic cells (DCs), initiate allergic inflammatory responses to allergic stimuli. However, it is unclear if A.f. spores during isotropic growth (early spore swelling) can activate DCs to initiate allergic responses or if germination is required
-
MRGPRX2 facilitates IgE-mediated systemic anaphylaxis in a newly established knock-in mouse model. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-22 Maram Bawazir,Sangita Sutradhar,Saptarshi Roy,Hydar Ali
BACKGROUND In addition to FcεRI, a subtype of human mast cells (MCs) expresses Mas-related G-protein coupled receptor X2 (MRGPRX2, mouse counterpart MrgprB2). Although MrgprB2 contributes to IgE-mediated passive systemic anaphylaxis (PSA) in vivo, an MRGPRX2 inhibitor (C9) does not block MrgprB2-mediated or IgE-mediated MC degranulation in vitro. OBJECTIVE To generate mice expressing human MRGPRX2
-
Expanding the Diagnostic Toolbox for Complex Genetic Immune Disorders. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-22 Eric D Abrams,Amrita Basu,Megan E Zavorka Thomas,Sarah E Henrickson,Roshini S Abraham
Laboratory-based immunology evaluation is essential to the diagnostic work-up of patients with complex immune disorders, and is as essential, if not more so, depending on the context, than genetic testing, as it enables identification of aberrant pathways amenable to therapeutic intervention, and clarifies variants of uncertain significance. There have been considerable advances in techniques and instrumentation
-
Leptin augments IL-13-induced airway eotaxins and submucosal eosinophilia in obesity-associated asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-22 Jennifer L Ingram,Victoria L McQuade,Jasmine Weiss,Jack T Womble,Mark D Ihrie,Karen Zhao,Dave Francisco,Barbara Theriot,Katelynn May,Haein Kim,Matthew McCravy,Maor Sauler,Njira L Lugogo,Mary E Sunday,Jeffrey Everitt,Julia K L Walker,Robert M Tighe,Monica Kraft,Loretta G Que
BACKGROUND Airway tissue eosinophilia can be an observed feature of obesity associated T2 asthma, but the processes mediating this inflammation are unknown. OBJECTIVE We investigated a process whereby leptin, an adipokine elevated in obesity, potentiates pulmonary eosinophilia and eotaxin production by airway fibroblasts in T2 asthma. METHODS We assessed associations between body mass index and airway
-
The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-22 Aikaterini Anagnostou,J Andrew Bird,Sharon Chinthrajah,Timothy E Dribin,David M Fleischer,Edwin Kim,Anna Nowak-Wegrzyn,Rima Rachid,Marcus S Shaker,Wayne Shreffler,Scott Sicherer,Jonathan Tam,Brian P Vickery,Yamini V Virkud,Julie Wang,Michael Young,Matthew Greenhawt
Omalizumab was recently approved by the US Food and Drug Administration for treatment of any single food allergy or multiple food allergies in children aged 1 year and older and adults. There is currently no formal guidance regarding recommended best practices for omalizumab use in food allergy, including patient selection, anticipated goals and outcomes of therapy, procedure for monitoring patients
-
Melatonin treatment increases skin microbiota-derived propionic acid to alleviate atopic dermatitis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-21 Lan Yang,Piao Wang,Ting Gao,Xinyu Huang,Zhen Lin,Evan Sweren,Yue Li,Lu Chen,Martin P Alphonse,Jianglin Zhang,Gaofeng Wang
BACKGROUND Melatonin has been reported to relieve the inflammatory symptoms and improve sleep disturbance in AD patients. Recent studies showed that melatonin exerted beneficial actions by remodeling intestinal microbiota composition; however, whether the beneficial effects of melatonin in AD were mediated by the modulation of skin microbiota remains unclear. OBJECTIVE We sought to investigate the
-
Food elimination in EoE: Milk before wheat, egg, and soy. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-19 Renée J Crawford,Benjamin L Wright
-
Stress-experienced monocytes/macrophages lose anti-inflammatory function via β2-adrenergic receptor in skin allergic inflammation. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-19 Hitoshi Urakami,Soichiro Yoshikawa,Kei Nagao,Kensuke Miyake,Yuki Fujita,Ayaka Komura,Miho Nakashima,Ryusuke Umene,Shuhei Sano,Zheyu Hu,Emi Nishii,Atsushi Fujimura,Takeshi Y Hiyama,Keiji Naruse,Hajime Karasuyama,Tsuyoshi Inoue,Mitsutoshi Tominaga,Kenji Takamori,Shin Morizane,Sachiko Miyake
BACKGROUND Psychological stress can exacerbate the development of allergies; however, the underlying mechanisms remain poorly understood. IgE-mediated cutaneous allergic inflammation (IgE-CAI) is a basophil-dependent skin allergy with eosinophil infiltration at inflammatory sites. Its resolution involves anti-inflammatory programmed death ligand 2 (PD-L2)-positive macrophages. OBJECTIVE This study
-
Lung function trajectories in common variable immunodeficiencies: An observational retrospective multicenter study. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-19 Helena Buso,Davide Firinu,Renato Finco Gambier,Riccardo Scarpa,Giulia Garzi,Valentina Soccodato,Giulia Costanzo,Andrea G Ledda,Nicolò Rashidy,Ilaria Bertozzi,Stefania Nicola,Giulio Tessarin,Mauro Ramigni,Cinzia Piovesan,Fabrizio Vianello,Andrea Vianello,Stefano Del Giacco,Vassilios Lougaris,Luisa Brussino,Mark G Jones,Isabella Quinti,Carlo Agostini,Marcello Rattazzi,Cinzia Milito,Francesco Cinetto
BACKGROUND Respiratory disease is a frequent cause of morbidity and mortality in common variable immunodeficiencies (CVIDs); however, lung function trajectories are poorly understood. OBJECTIVE We sought to determine lung physiology measurements in CVIDs, their temporal trajectory, and their association with clinical and immunologic parameters. METHODS This retrospective study from 5 Italian centers
-
Omalizumab: The journey of the first anti-IgE approved for asthma and allergic disorders. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-18 Thomas B Casale
-
Coronavirus disease 2019 (COVID-19) in children: Evolving epidemiology, immunology, symptoms, diagnostics, treatment, post-COVID-19 conditions, prevention strategies, and future directions. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-17 Juliane Wurm,Nicole Ritz,Petra Zimmermann
The epidemiology of coronavirus disease 2019 (COVID-19) in children has evolved throughout the pandemic, with initially low infection rates rising significantly as a result of the emergence of the more transmissible Omicron variant. Adolescents, children from ethnic minorities and lower-income households, and those with obesity are at increased risk of contracting severe acute respiratory syndrome
-
An updated review of the use of omalizumab for the treatment of uncontrolled pediatric allergic asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-15 Bradley E Chipps,Meghan Farrell Garcia,Kevin R Murphy,Tmirah Haselkorn
Asthma has been increasingly recognized as a heterogeneous disease; however, many patients with asthma suffer from allergic asthma. While inhaled corticosteroids and other inhalers have been integral in treating many symptoms of asthma, these medications do not completely address the underlying mechanism of the disease. Pediatric asthma imposes a substantial burden on patients and the healthcare system
-
Anti-IgE therapy in chronic rhinosinusitis with nasal polyps. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-15 Krishan D Chhiba,Gayatri B Patel,Anju T Peters
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory condition characterized by type 2 (T2) immune responses with significant impacts on quality of life and healthcare costs. Local IgE production in nasal polyp tissue plays a key role in the T2 inflammatory cascade. Omalizumab, an anti-IgE monoclonal antibody, is an effective treatment for some patients with CRSwNP regardless
-
Making Sense of Adenosine Deaminase Variants and Their Clinical Implications. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-15 Eyal Grunebaum,Robyn Loves,Donald B Kohn
-
Importance of mast cell histamine secretion in IgG-mediated systemic anaphylaxis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-15 Marat V Khodoun,Richard T Strait,Ashley Hall,Adrienne Stolfi,Fred D Finkelman
BACKGROUND IgG can mediate murine and human systemic anaphylaxis (SA). The roles of mast cells (MCs) and histamine in IgG-mediated anaphylaxis are controversial for mice and have not been studied in vivo for humans. We are now investigating these issues. METHODS Actively or passively sensitized wild-type and immune-deficient mice were induced to develop anaphylaxis by intravenous antigen challenge
-
Bruton's tyrosine kinase (BTK) and matrix metalloproteinase-9 (MMP-9) regulate NLRP3 inflammasome-dependent cytokine and neutrophil extracellular trap responses in primary neutrophils. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-14 Vinicius N C Leal,Francesca Bork,Maria Mateo Tortola,Juli-Christin von Guilleaume,Carsten L Greve,Stefanie Bugl,Bettina Danker,Zsofia A Bittner,Bodo Grimbacher,Alessandra Pontillo,Alexander N R Weber
BACKGROUND Inflammation is a double-edged state of immune activation that is required to resolve threats harmful to the host, but can also cause severe collateral damage. Polymorphonuclear neutrophils (PMNs), the primary leukocyte population in humans, mediate inflammation through the release of cytokines and neutrophil extracellular traps (NETs). Although the pathophysiological importance of NETs
-
Early-life upper airway microbiota are associated with decreased lower respiratory tract infections. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-14 Susan Zelasko,Mary Hannah Swaney,Shelby Sandstrom,Kristine E Lee,Jonah Dixon,Colleen Riley,Lauren Watson,Jared J Godfrey,Naomi Ledrowski,Federico Rey,Nasia Safdar,Christine M Seroogy,James E Gern,Lindsay Kalan,Cameron Currie
BACKGROUND Microbial interactions mediating colonization resistance play key roles within the human microbiome, shaping susceptibility to infection from birth. The role of the nasal and oral microbiome in the context of early life respiratory infections and subsequent allergic disease risk remains understudied. OBJECTIVES Our aim was to gain insight into microbiome-mediated defenses and respiratory
-
Developmental trajectories of atopic dermatitis with multiomics approaches in the infant gut: COCOA birth cohort. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-14 Eun Lee,Jeong-Hyun Kim,So-Yeon Lee,Si Hyeon Lee,Yoon Mee Park,Hea Young Oh,Jeonghun Yeom,Hee-Sung Ahn,Hyun Ju Yoo,Bong-Soo Kim,Sun Mi Yun,Eom Ji Choi,Kun Baek Song,Min Jee Park,Kangmo Ahn,Kyung Won Kim,Youn Ho Shin,Dong In Suh,Joo Young Song,Soo-Jong Hong
BACKGROUND An understanding of the phenotypes and endotypes of atopic dermatitis (AD) is essential for developing precision therapies. Recent studies have demonstrated evidence for the gut-skin axis in AD. OBJECTIVE We sought to determine the natural course and clinical characteristics of AD phenotypes and investigate their mechanisms on the basis of multiomics analyses. METHODS Latent class trajectory
-
Addressing health disparities in food allergy: A Position Statement of the AAAAI Prior Authorization Task Force. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-13 ,
Self-reported food allergies (FAs) affect approximately 8% of the US pediatric and approximately 10% of the adult population, which reflects potentially disproportionate increases among ethnically and racially minoritized groups. Multiple gaps and unmet needs exist regarding FA disparities. There is reported evidence of disparities in FA outcomes, and the FA burden may also be disproportionate in low-income
-
Mesenchymal stem cell-derived small extracellular vesicles restored nasal barrier function in allergic rhinitis via miR-143-GSK3B in human nasal epithelial cells. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-12 Meiqian Xu,Mei Ren,Xinyin Zhang,Wenxu Peng,Hao Li,Wenjing Liao,Jianlei Xie,Xiaowen Zhang
BACKGROUND The nasal epithelial barrier is the first line of defense against the deep entry of pathogens or aeroallergens and is more critical in allergic rhinitis (AR). Restoring epithelial barrier dysfunction might be a promising strategy for AR. Recent studies reported that mesenchymal stem cell-derived small extracellular vesicles (MSC-sEV) potentially inhibit the inflammation response and promote
-
Analysis of human neutrophils from nasal polyps by single-cell RNA sequencing reveals roles of neutrophils in chronic rhinosinusitis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-09 Naruhito Iwasaki,Julie A Poposki,Masanori Kidoguchi,Aiko Oka,Aiko I Klingler,Whitney W Stevens,Lydia A Suh,Junqin Bai,Anju T Peters,Leslie C Grammer,Kevin C Welch,Stephanie S Smith,David B Conley,Bruce S Bochner,Robert P Schleimer,Robert C Kern,Bruce K Tan,Atsushi Kato
BACKGROUND Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by type 2 (T2) inflammation. Recent studies, including our own, suggest that neutrophils are also elevated in T2 nasal polyps (NP) and that elevated neutrophils display an activated phenotype. However, the actual roles of neutrophils in NP pathogenesis in T2 CRSwNP are still largely unclear. OBJECTIVE To reveal the roles
-
Profiling immune cell tissue niches in the spatial -omics era. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-08 Colin Y C Lee,James McCaffrey,Dominic McGovern,Menna R Clatworthy
Immune responses require complex, spatially coordinated interactions between immune cells and their tissue environment. For decades, we have imaged tissue sections to visualize a limited number of immune-related macromolecules in situ, functioning as surrogates for cell types or processes of interest. However, this inevitably provides a limited snapshot of the tissue's immune landscape. Recent developments
-
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-08 Stephan Weidinger,Andrew Blauvelt,Kim A Papp,Adam Reich,Chih-Hung Lee,Margitta Worm,Charles Lynde,Yoko Kataoka,Peter Foley,Xiaodan Wei,Wanling Wong,Anne-Catherine Solente,Christine Weber,Samuel Adelman,Sonya Davey,Fabrice Hurbin,Natalie Rynkiewicz,Karl Yen,John T O'Malley,Charlotte Bernigaud
BACKGROUND Amlitelimab, a fully human nondepleting mAb targeting OX40 ligand on antigen-presenting cells, could prevent T-cell-driven inflammation seen in atopic dermatitis (AD). OBJECTIVE This trial evaluated the efficacy and safety of amlitelimab in adults with AD. METHODS In this 2-part, phase 2b, randomized, double-blinded placebo-controlled trial (ClinicalTrials.gov identifier NCT05131477), patients
-
Implementation of the esophageal string test in clinical practice and research. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-08 Shauna Schroeder,Cindy S Bauer,Benjamin L Wright
-
Booster vaccination normalizes postvaccination immunity in patients with severe asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-08 Hitasha Rupani,Rekha Chaudhuri,David J Jackson,Helen Moyses,Ramesh J Kurukulaaratchy,Hans Michael Haitchi,Michael R Edwards,Sebastian L Johnston,Ratko Djukanovic
-
Impact of biologics on the immune response to mRNA COVID-19 vaccination in patients with asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-08 Shu-Yi Liao,Barry Make,Michael E Wechsler
-
Prevalence and outcomes of cancer and treatment-associated toxicities for patients with ataxia telangiectasia. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-08 Aimee Magnarelli,Qi Liu,Fan Wang,Xiao P Peng,Jennifer Wright,Ninad Oak,Valerie Natale,Cynthia Rothblum-Oviatt,Maureen A Lefton-Greif,Sharon McGrath-Morrow,Thomas O Crawford,Matthew J Ehrhardt,Howard M Lederman,Richa Sharma
BACKGROUND Ataxia telangiectasia (A-T) is a DNA repair disorder with cancer predisposition. OBJECTIVE We sought to characterize the prevalence and outcomes of hematologic and solid cancers and treatment-associated toxicities in individuals with A-T. METHODS Data were retrospectively analyzed from the Johns Hopkins Ataxia Telangiectasia Clinical Center cohort. Cumulative incidence and standardized incidence
-
Association between allergic diseases and mental health conditions: An umbrella review. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Xianpeng Xu,Sha Li,Yingjie Chen,Xinxing Deng,Jiongke Li,Dajing Xiong,Hui Xie
BACKGROUND The mental health conditions of allergic diseases have been investigated, but the consistency and magnitude of their effects are unclear. The aim of this umbrella review was to systematically evaluate the published evidence on allergic diseases and mental health conditions to establish a new hierarchy of evidence and identify gaps in this area of research. METHODS We systematically searched
-
Targeting of the IL-5 pathway in severe asthma reduces mast cell progenitors. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 P Abigail Alvarado-Vazquez,Erika Mendez-Enriquez,Maya Salomonsson,Peter Kopac,Ana Koren,Urska Bidovec-Stojkovic,Sabina Škrgat,Oscar E Simonson,Valentyna Yasinska,Sven-Erik Dahlén,Gunnar Pejler,Christer Janson,Peter Korosec,Andrei Malinovschi,Jenny Hallgren
BACKGROUND Therapies targeting IL-5 or its receptor (IL-5Rα) are currently used to treat patients with severe eosinophilic asthma. OBJECTIVE We sought to investigate the impact of anti-IL-5 and anti-IL-5Rα biological therapies on mast cells (MCs) and their progenitors. METHODS Surface IL-5Rα expression was investigated on MCs and their progenitors in mouse lungs and bone marrow and in human lungs and
-
Unravelling the noise in pharmacokinetic studies of epinephrine: Time to focus on cardiac output? J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Nandinee Patel,Lucy Hawkins,Paul J Turner
-
Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Javier S Cabrera-Perez,Vincent J Carey,Oreofe O Odejide,Sonal Singh,Thomas S Kupper,Shiv S Pillai,Scott T Weiss,Ayobami Akenroye
BACKGROUND There have been multiple reports of the anti-IL-4Rα agent, dupilumab, being associated with the onset and/or progression of cutaneous T-cell lymphoma (CTCL). OBJECTIVE We sought to evaluate safety signals associated with dupilumab, with a focus on CTCL, and to evaluate the possible underlying mechanism or mechanisms for the potential association. METHODS First, we used the Food and Drug
-
IL-9 sensitizes human TH2 cells to proinflammatory IL-18 signals in atopic dermatitis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Stefanie Schärli,Fabian Luther,Jeremy Di Domizio,Christina Hillig,Susanne Radonjic-Hoesli,Kathrin Thormann,Dagmar Simon,Amalie Thorsti Møller Rønnstad,Iben Frier Ruge,Blaine G Fritz,Thomas Bjarnsholt,Angela Vallone,Sanja Kezic,Michael P Menden,Lennart M Roesner,Thomas Werfel,Jacob P Thyssen,Stefanie Eyerich,Michel Gilliet,Nicole L Bertschi,Christoph Schlapbach
BACKGROUND TH2 cells crucially contribute to the pathogenesis of atopic dermatitis (AD) by secreting high levels of IL-13 and IL-22. Yet the upstream regulators that activate TH2 cells in AD skin remain unclear. IL-18 is a putative upstream regulator of TH2 cells because it is implicated in AD pathogenesis and has the capacity to activate T cells. OBJECTIVE We sought to decipher the role of IL-18 in
-
Current status and future directions in Food Protein-Induced Enterocolitis Syndrome (FPIES): An NIAID Workshop Report. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Anna Nowak-Wegrzyn,Scott H Sicherer,Cem Akin,Sara Anvari,Lisa M Bartnikas,M Cecilia Berin,Theresa A Bingemann,Scott Boyd,Terri Brown-Whitehorn,Supinda Bunyavanich,Antonella Cianferoni,George du Toit,John E Fortunato,Jeffrey D Goldsmith,Marion Groetch,Stephanie A Leonard,Meenakshi Rao,Fallon Schultz,Julie M Schwaninger,Carina Venter,Amity Westcott-Chavez,Robert A Wood,Alkis Togias
Food Protein-Induced Enterocolitis (FPIES) is a non-IgE mediated GI food allergy characterized by delayed, protracted vomiting, accompanied by lethargy and pallor, usually 1-4 hours following ingestion of the food allergen. The pathophysiology of FPIES remains unknown and currently there are no diagnostic biomarkers available to assess disease activity or its resolution. Over the last two decades,
-
Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Kalliopi Domvri,Ioanna Tsiouprou,Petros Bakakos,Paschalis Steiropoulos,Konstantinos Katsoulis,Konstantinos Kostikas,Katerina M Antoniou,Andriana I Papaioannou,Nikoletta Rovina,Paraskevi Katsaounou,Theodora Papamitsou,Nicoleta Pastelli,Stavros Tryfon,Evangelia Fouka,Despoina Papakosta,Stelios Loukides,Konstantinos Porpodis
BACKGROUND Clinical trials and real-world experience have provided evidence for the clinical benefits of mepolizumab, an anti-IL-5 biologic, in severe asthma. However, limited data exist regarding the impact of mepolizumab on airway remodeling. OBJECTIVE We sought to investigate the effect of mepolizumab on airway structural remodeling in patients treated for severe asthma in routine clinical care
-
IgG4 and eosinophilic esophagitis: Bridging the knowledge gap. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-07 Laura Franceschini,Alessandro Farsi
-
Newborn screening for SCID and severe T lymphocytopenia in Europe. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-06 Maartje Blom,Maarja Soomann,Pere Soler-Palacín,Anna Šedivá,Asbjørg Stray-Pedersen,Rolf Zetterström,Carsten Speckmann,Andrew R Gennery,Mirjam van der Burg
Initiation of newborn screening (NBS) programs in Europe dates back to the 1960s. One of the most recent expansions of NBS programs was the addition of severe combined immunodeficiency (SCID) based on detection of T-cell receptor excision circles (TRECs). In this review, we present an overview of the current situation in Europe. To avoid a biased overview based on only published results, a 37-item
-
Baseline epitope-specific IgE profiles are predictive of sustained unresponsiveness or high threshold 1-year post oral immunotherapy in the POISED trial. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-05 Maria Suprun,Ashley Sang Eun Lee,Robert Getts,Simon Peck,Sayantani B Sindher,Kari C Nadeau,R Sharon Chinthrajah,Stephen J Galli,Hugh A Sampson
BACKGROUND Results from the POISED trial suggest that discontinuation of peanut oral immunotherapy can increase the risk of regaining clinical reactivity to peanut. OBJECTIVE We sought to determine whether patients who achieved sustained unresponsiveness (SU) or sustained high threshold (SHT) have different baseline sequential epitope-specific IgE profiles than patients who achieved transient desensitization
-
Association of CD19+-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortality. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-11-04 Natalia M Sutherland,Baijun Zhou,Lingxiao Zhang,Mei-Sing Ong,Joseph S Hong,Andrew Pak,Katherine J Liu,Matthew J Frigault,Marcela V Maus,Joshua A Hill,Kerry Reynolds,Jolan E Walter,Carlos A Camargo,Sara Barmettler
BACKGROUND CD19-targeted chimeric antigen receptor T-cell therapy (CAR-T therapy) has revolutionized the treatment of hematologic malignancies. As these cells target CD19+ receptors on B cells, there is the potential for B-cell aplasia and hypogammaglobulinemia. Data on the degree and clinical significance of hypogammaglobulinemia are sparse. OBJECTIVES We sought to evaluate hypogammaglobulinemia after
-
Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR). J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-31 Sven F Seys,Sven Schneider,Joost de Kinderen,Sietze Reitsma,Carlo Cavaliere,Peter-Valentin Tomazic,Christina Morgenstern,Geoffrey Mortuaire,Martin Wagenmann,Giulia Bettio,Andrea Ciofalo,Zuzana Diamant,Julia Eckl-Dorna,Wytske J Fokkens,Clemens Holzmeister,Gert Mariën,Simonetta Masieri,Josje Otten,Kathrin Scheckenbach,Aldine Tu,Claus Bachert,
BACKGROUND Pivotal studies with dupilumab demonstrated clinically relevant improvements in nasal polyp score, symptom score, and quality-of-life score in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). OBJECTIVE We evaluated the effectiveness of dupilumab in a large-scale CRSwNP cohort from 6 European tertiary-care centers. METHODOLOGY Nasal polyp score, Sinonasal Outcome Test 22 score
-
Sensory neuroimmune signaling in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2024-10-29 Xiaobao Huang,Suiting Ao,Rui Xu,Xuemei Gao,Shiling Qi,Yarong Liang,Peiying Feng,Ruzeng Xue,Yingying Ren,Jiande Han,Fengxian Li,Coco Chu,Fang Wang
BACKGROUND Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening cutaneous reactions often triggered by medications. While the involvement of CD8+ T cells causing keratinocyte death is well recognized, the contribution of neural elements to the persistent skin inflammation has been largely overlooked. OBJECTIVE We investigated the potential neuroimmune regulation